Co-Authors
This is a "connection" page, showing publications co-authored by Christos Krogias and Dirk Bartig.
Connection Strength
0.821
-
A full year of the COVID-19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany. Eur J Neurol. 2022 01; 29(1):105-113.
Score: 0.241
-
Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany. Stroke. 2021 01; 52(2):716-721.
Score: 0.230
-
Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany. Neurol Res Pract. 2021 Aug 16; 3(1):42.
Score: 0.060
-
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany. Ther Adv Neurol Disord. 2021; 14:17562864211030656.
Score: 0.060
-
Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany. Mov Disord. 2021 05; 36(5):1049-1057.
Score: 0.059
-
Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany. Parkinsonism Relat Disord. 2021 04; 85:109-113.
Score: 0.058
-
Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis. Neurol Res Pract. 2020; 2:48.
Score: 0.057
-
Letter to the editor: risk comorbidities of COVID-19 in Parkinson's disease patients in Germany. Neurol Res Pract. 2020; 2(1):22.
Score: 0.056